Literature DB >> 21866887

Cationic derivatives of dextran and hydroxypropylcellulose as novel potential heparin antagonists.

Kamil Kamiński1, Monika Płonka, Justyna Ciejka, Krzysztof Szczubiałka, Maria Nowakowska, Barbara Lorkowska, Ryszard Korbut, Radosław Lach.   

Abstract

Cationic derivatives of dextran (Dex) and hydroxypropylcellulose (HPC) were studied as potential alternatives of protamine sulfate (PS) used in the reversal of anticoagulant activity of heparin. The modification was performed by the attachment of cationic groups to the Dex main chain or by grafting short side chains of a polycation onto HPC. The cationic derivatives of these polysaccharides were found to bind heparin with the efficiency increasing with growing degree of cationic modification. The degree of cationic modification and consequently the ζ potential of the polymers do not have to be high to achieve effective heparin binding. The size of the complexes of cationic Dex with unfractionated heparin (UFH) is a few micrometers. For complexes of cationic HPC and UFH the size is much below 1 μm, both below and above the lower critical solution temperature of HPC. None of the cationic polysaccharides studied caused hemolysis. The concentrations of the polymers inducing the aggregation of human erythrocytes in vitro were determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866887     DOI: 10.1021/jm200380w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

Review 1.  Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.

Authors:  Manu Thomas Kalathottukaren; Charles A Haynes; Jayachandran N Kizhakkedathu
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

2.  Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparin.

Authors:  Bartlomiej Kalaska; Kamil Kaminski; Emilia Sokolowska; Dominik Czaplicki; Monika Kujdowicz; Krystyna Stalinska; Joanna Bereta; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

3.  The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin.

Authors:  Emilia Sokolowska; Bartlomiej Kalaska; Kamil Kaminski; Alicja Lewandowska; Agnieszka Blazejczyk; Joanna Wietrzyk; Irena Kasacka; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

4.  Growth of Lactic Acid Bacteria on Gold-Influence of Surface Roughness and Chemical Composition.

Authors:  Joanna Grudzień; Magdalena Jarosz; Kamil Kamiński; Mirosława Kobasa; Karol Wolski; Marcin Kozieł; Marcin Pisarek; Grzegorz D Sulka
Journal:  Nanomaterials (Basel)       Date:  2020-12-13       Impact factor: 5.076

5.  The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target.

Authors:  Bartlomiej Kalaska; Joanna Miklosz; Kamil Kamiński; Bogdan Musielak; Shin-Ichi Yusa; Dariusz Pawlak; Maria Nowakowska; Krzysztof Szczubiałka; Andrzej Mogielnicki
Journal:  RSC Adv       Date:  2019-01-23       Impact factor: 4.036

6.  Serum Albumin-Peptide Conjugates for Simultaneous Heparin Binding and Detection.

Authors:  Qing Liu; Salla Välimäki; Ahmed Shaukat; Boxuan Shen; Veikko Linko; Mauri A Kostiainen
Journal:  ACS Omega       Date:  2019-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.